Journal article : Review
Crossing the finish line towards a disease-modifying treatment for Angelman syndrome
- Abstract:
- Recent progress in the development of genetic therapies promises that impactful treatments for single-gene neurodevelopmental disorders are imminent. But can derailed neurodevelopmental processes be mended after broken genes are replaced or otherwise restored? The results of ongoing clinical trials for Angelman syndrome will soon yield answers to this pressing question, yet the trials face significant obstacles. Here we identify insights needed to aid the quest for a disease-modifying Angelman syndrome therapy, which could serve as a roadmap for the expeditious development of genetic therapies for other single-gene neurodevelopmental disorders.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.2MB, Terms of use)
-
- Publisher copy:
- 10.1186/s11689-026-09681-5
Authors
- Publisher:
- BioMed Central
- Journal:
- Journal of Neurodevelopmental Disorders More from this journal
- Volume:
- 18
- Issue:
- 1
- Article number:
- 15
- Publication date:
- 2026-03-07
- Acceptance date:
- 2026-02-23
- DOI:
- EISSN:
-
1866-1955
- ISSN:
-
1866-1947
- Language:
-
English
- Keywords:
- Subtype:
-
Review
- Pubs id:
-
2392448
- Local pid:
-
pubs:2392448
- Source identifiers:
-
3868142
- Deposit date:
-
2026-03-19
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record